Tuesday, November 13, 2018

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: NASDAQ: $CRON, TSX: $CRON.TO, TSXV: $FIRE.V, CSE: $GGB.C, CSE: $ASNT.C, CSE: $MTEC.C

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: NASDAQ: $CRON, TSX: $CRON.TO, TSXV: $FIRE.V, CSE: $GGB.C, CSE: $ASNT.C, CSE: $MTEC.C



Investor Ideas Potcasts #Cannabis News and Stocks on the Move: NASDAQ: $CRON, TSX: $CRON.TO, TSXV: $FIRE.V, CSE: $GGB.C, CSE: $ASNT.C, CSE: $MTEC.C


Delta, Kelowna, BC - November 13, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Cannabis Life Sciences a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries will be showcasing at MJBizCon this week in Las Vegas from November 14-16th.
Investorideas.com will be at MJBizCon this week at Podcasters Row interviewing industry leaders and experts.
Listen to the podcast:

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: NASDAQ: $CRON, TSX: $CRON.TO, TSXV: $FIRE.V, CSE: $GGB.C, CSE: $ASNT.C, CSE: $MTEC.C

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:
Good morning and welcome to today's edition of Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts, brought to you with this month's content partner, CLS Holdings USA, Inc. (OTCQB: CLSH).
Today we will be looking at announcements from Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON), The Supreme Cannabis Company, Inc. (TSXV: FIRE), Xanthic Biopharma Inc. d.b.a. Green Growth Brands (CSE:GGB), Ascent Industries Corp. (CSE: ASNT) and Cannvas MedTech Inc. (CSE: MTEC)
Cronos Group Inc. announced financial results for the third quarter ended September 30, 2018.
"We are encouraged with our third quarter results, which reflect the meaningful progress we are making on our strategic initiatives. In the quarter, we announced a number of landmark partnerships to expand our reach beyond the flower and beyond Canada and launched our second differentiated recreational cannabis brand," said Mike Gorenstein, CEO of Cronos Group. "The recent legalization of cannabis sales for adult recreational use in Canada was a watershed moment for our industry and our Company. We are energized by the opportunities this creates for Cronos Group in Canada and look forward to leading the industry forward responsibly."
"As excited as we are about this milestone and our participation in this new market, it's truly just the beginning. Cronos Group is building an innovative global cannabinoid company. The opportunities for our Company extend across the globe as regulations evolve and markets open. The recent initiatives we launched with Gingko Bioworks and Technion are great examples of how we intend to use innovation and our growing intellectual property portfolio to develop new applications for cannabinoids across a range of categories. We are proud of all that we accomplished this quarter, and we are focused on executing on our strategic plan to drive growth and value creation for our shareholders, partners and consumers," concluded Mike Gorenstein.
Highlights from the third quarter 2018 included revenues which totaled $3.8 million, as compared to $1.3 million for the third quarter of 2017, representing an increase of $2.4 million, or 186%. Kilograms of cannabis sold increased 213% in the third quarter from 164 kilograms in the third quarter of 2017 to 514 kilograms in the third quarter of 2018. The main drivers associated with the increase in revenues and the increase in kilograms sold are increased production capacity and increased volumes sold through the domestic medical and international channels, as well as initial shipments into the domestic adult-use recreational market.
The Company also continues to see strong growth in cannabis oil sales, which represented 29% of total revenue in the third quarter of 2018.
The Supreme Cannabis Company, Inc. announced today that it has entered into a definitive agreement to acquire leading communications and stakeholder relations firm Bayfield Strategy, Inc. Bayfield's CEO, founder and shareholder, Riyaz Lalani, will be appointed to the position of Chief Corporate Officer of the Company where he will help shepherd the Company through its next stage of growth as a leading premium cannabis producer in the world. Bayfield's employees will enter into employment agreements with Supreme Cannabis and assume a variety of roles in corporate operations and stakeholder relations.
Over the last two decades, Mr. Lalani has advised public companies, boards of directors, private equity funds and hedge funds across North America. Prior to founding Bayfield, Mr. Lalani was the Chief Operating Officer of the leading shareholder services firm in Canada. Beforehand he was the head of research for an international asset manager in New York and Toronto, focused on investments in biotechnology, life sciences, resources, and a variety of other industry sectors. Mr. Lalani will contribute a unique and diverse experience set that encompasses capital allocation, strategic communications, and operational execution.
Xanthic Biopharma Inc. d.b.a. Green Growth Brands made its trading debut on the Canadian Securities Exchange (CSE) at today's market open under the ticker symbol "GGB". The highly-anticipated listing on the CSE represents the completion of the reverse takeover (RTO) announced by the Company in July 2018.
"Our listing on the Canadian Securities Exchange represents a significant milestone in the journey of building Green Growth Brands," said Peter Horvath, CEO of GGB's operating entity. "The transition to a publicly-traded company will benefit our current investors, give new investors a chance to join us and provide the Company with the currency to facilitate our aggressive growth plan."
"Our team has run multi-billion dollar businesses, operating as number ones in their respective categories, competing for customers in saturated mature markets. We're eager to do it again in the burgeoning North American cannabis industry," continued Horvath.
Ascent Industries Corp., through its wholly owned subsidiary, Thirty Eight Hemp Corp., continues to prepare for an emerging hemp and CBD market. The regulatory regime in the United States relating to CBD is undergoing a significant transformation and the Company believes that the recent mid-term elections in the United States were a positive indication of this. The movement towards the removal of hemp (cannabis with less than 0.3% THC content) from Schedule I of the United States Controlled Substances Act ("CSA") is gaining momentum. When the United States Hemp Farming Act of 2018 (the "Hemp Farming Act") is enacted, hemp is expected to be fully de-scheduled from the CSA, making it an ordinary agricultural commodity and providing a significant market opportunity for hemp derived products.
Through its unique strategic relationship with AgTech Scientific Inc. of Paris, Kentucky, the Company plans to exploit the opportunity expected in the hemp markets to significantly expand its distribution of CBD-based products throughout the United States and internationally.
Ascent's Chief Operating Officer, Reid Parr commented, "The are many reasons for this strategic relationship, but the main reason is that compared to their competitors, AgTech has true vertical integration. They have world class genetics, large scale farming including outdoor and indoor high-tech greenhouses as well as large scale, GMP compliant, state of the art extraction and product manufacturing."
Cannvas MedTech Inc., a leader in digital cannabis education and a leading business technology company in the cannabis space, and Medical Marihuana Patient Relief Inc., a private late-stage ACMPR license applicant, announced the signing of a letter of intent to negotiate, in good faith, a joint marketing agreement whereby the two companies will work together to market and promote cannabis education. Cannvas will become the exclusive provider of cannabis information and education to the MM Patient Relief website and the MM Patient Relief product line will be integrated into the Cannvas Kiosk platform and featured in Cannvas Marché locations on digital marketing screens with fulfillment opportunities.
"We are building MM Patient Relief to be the most physician centric, data driven licensed producer to meet the needs of sophisticated clients who are looking for an effective alternative to pharmaceuticals," said Alex Ciotoli, President, Medical Marihuana Patient Relief Inc. "Working with Cannvas enables us to have the latest education content which is a core component to meeting our objectives."
This podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) - more info and details can be found at our disclaimer and disclosure page at Investorideas.com
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by

CLS Holdings USA, Inc. (OTCQB: CLSH)
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
For additional information, please visit: http://www.clsholdingsinc.com
Twitter: @CLSHusa

Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411

No comments: